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1. Introduction 
Despite the remarkable advances in the peri-operative management of the liver transplant 
recipient, the post-reperfusion syndrome (PRS) continues to be an important intra-
operative risk factor for impaired graft function, and morbidity and mortality of the 
recipient. In order to institute preventive measures several studies have attempted to 
elucidate risk factors for PRS. Those identified risk factors and proposed mechanisms 
underlying the development of PRS, as well as current issues with PRS will be discussed 
in the following three sections. 
2. Diagnosis 
The post-reperfusion syndrome (PRS) which occurs during liver transplantation was first 
diagnosed by Aggarwal et al in 1987 and described as cardiovascular collapse following 
revascularization of the liver graft. They defined PRS as severe hemodynamic instability, 
persistent hypotension (a greater than 30% drop below the anhepatic mean arterial blood 
pressure (MAP) within 5 minutes of reperfusion and sustained for at least 1 minute), 
accompanied by asystole, or significant arrhythmias as well as development of significant, 
fibrinolysis requiring treatment. Up until now this definition remains the same with some 
modifications. Hilmi et al defined mild PRS as a drop in MAP to less than 30% of mean 
baseline MAP observed during the anhepatic stage associated with bradycardia and 
sustained for less than 5 minutes, and requiring calcium or epinephrine boluses, but without 
the need for continuous vasopressor infusion. Severe PRS was defined as persistent severe 
hypotension with a greater than 30% reduction in MAP from mean baseline MAP during the 
anhepatic stage, associated with asystole, significant arrhythmias, and requiring   prolonged 
vasopressor infusion (until end of surgery) and fibrinolysis. Other reports have used only 
persistent hypotension as the defining endpoint for PRS. Therefore, inconsistency of 
definitions makes it difficult to draw conclusions concerning the precise incidence of PRS, its 
clinical presentation and causes. 
These definitions rely on the value of the percent change in MAP from the mean baseline 
MAP observed during the anhepatic stage. It so happens that the anhepatic stage is fraught 
with hemodynamic fluctuations related to manipulation of the inferior vena cava (IVC), 
blood loss, veno-venous bypass, hypothermia, metabolic acidosis, etc., which are common 
during the an-hepatic phase. These multi-factorial hemodynamic perturbations call into  
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Severe hemodynamic instability 
Persistent hypotension 
Geater than 30% of the anhepatic MAP within 5 
minutes sustained for at least 1 minute 
Asystole 
Significant arrhythmias 
Development of significant fibrinolysis 
Table 1. Definition of Post-Reperfusion Syndrome (PRS) Abbreviations: MAP: Mean Arterial 
Blood Pressure 
question the reliability and accuracy of PRS incidence and severity based on one parameter 
namely, % change in MAP. Moreover, pre-treatment with bolus doses of vasopressors, 
including calcium chloride, vasopressin or methylene blue immediately prior to reperfusion 
of the portal vein, intended to preempt severe hypotension post-reperfusion also introduce 
errors into the calculation of % changes in MAP, before and after reperfusion. More 
importantly, in some instances there may be a complete absence of hemodynamic instability 
even in the presence of severe graft dysfunction following reperfusion when portal vein 
flow is inadequate. This is called the no-reflow phenomenon. No-reflow is associated with 
high vascular resistance in the microcirculation of the graft secondary to multiple factors, 
such as: tissue edema, leukocyte plugging and the accumulation of pro-inflammatory factors 
and cellular debris; vasoconstriction of the tissues due to cold preservation, portal vein 
thrombosis, or presence of large collateral veins (porto-systemic shunts). In those cases, 
there is a gradual resolution of no-reflow and hemodynamic fluctuations may be delayed 
beyond the immediate portal vein or even hepatic artery reperfusion periods when the 
organ is better perfused. For these reasons, PRS incidence may not be accurately ascertained 
when a narrow window of MAP readings is used in its determination. Likewise, major 
changes in MAP in the immediate post-reperfusion period may or may not be associated 
with graft quality. Although cardiovascular collapse following reperfusion is common in 
liver transplant practice, it is essential to elucidate the underlying mechanisms of PRS, and 
to determine more accurately the relationship between PRS and graft quality. Is PRS a cause 
of poor graft quality or is it a consequence? The definitive answer to this question can only 
be found in the conduct of a blinded controlled prospective study with well-defined end 
points in a large cohort of patients. The results of such a study would help to broaden the 
scope of what constitutes the diagnosis of PRS. 
3. Incidence of PRS and confounding factors 
To date, there is wide variation in the reported incidence of PRS (5.9-61.3%). There are 
several factors attributable to these wide variations, among these are: differences in surgical 
technique, intraoperative hemodynamic management, as well as chronological and 
geographical factors. Piggyback technique is used for implantation of the liver graft without 
interrupting IVC flow. It was first introduced into human liver transplantation in the late 
1980’s. Veno-venous bypass (VVB) was also introduced in the 1980’s. Those techniques were 
developed to enable more stable hemodynamics upon manipulation of the IVC during 
orthotopic liver transplantation. Because volume status of the recipient before reperfusion 
can be an important risk factor for PRS, more stable hemodynamics before reperfusion may 
decrease its incidence, although the impact of surgical technique between conventional or  
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Author Year N Country Type of Study
Incidence of 
PRS
Identified Risk Factors for PRS
Ryu HG et. al. 2011 62 Korea Blind Controlled 
Prospective Study
-
Garcia-Gil FA et al. 2011 153 Spain Blind Controlled 
Prospective Study
-
Bukowicka B et al. 2011 340 Poland
Retrospective Chart 
Review
12.1%
Fukazawa K et al. 2011 715 USA
Retrospective Chart 
Review
55.7%
Siniscalchi A et al. 2010 58 Italy
Retrospective Chart 
Review
41.0%
Paugam-Burtz et al. 2009 75 France Prospective Study 25.0%
Hilmi I et al. 2008 338 USA
Retrospective Chart 
Review
55.0%
Ko JS et. al. 2008 87 Korea
Retrospective Chart 
Review
28.6% (UW) 
61.3% (HTK)
Homvises B et. al. 2008 20 Thailand
Retrospective Chart 
Review
-
Pertejo MA et. al. 2007 551 Spain
Retrospective Chart 
Review
16-27%
Vasodilator release form graft l
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Moreno et. al. 2006 30 Spain Randomized 
Prospective Study
36% (HAR) 
42.5% (PVR)
Ayanoglu et al. 2003 145 Turkey
Retrospective Chart 
Review
48.9%
Nanashima et al. 2001 93 Australia
Retrospective Chart 
Review
29.0%
Chui A K et al. 2000 321 Australia
Retrospective Chart 
Review
12.8%
Acosta F et al. 1999 32 Spain
Retrospective Chart 
Review
-
Acosta F et al. 1999 41 Spain
Retrospective Chart 
Review
-
Acosta F et al. 1999 71 Spain
Retrospective Chart 
Review
-
Garutti M et al. 1997 94 Spain
Retrospective Chart 
Review
28.7%
Jugan E et al. 1992 58 France Prospective Study 20.0%
(No difference between with a
without VVB)
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piggy-back techniques on PRS is still in debate. In addition, VVB reduces small bowel 
edema, which has been suggested as a primary site for the production and release of potent 
vasoactive inflammatory mediators.  With the improvement of transplant outcomes and 
recognition of risk factors for graft survival, expanded criteria donors (ECD) have been 
more frequently used due to severe shortages of organ donors. More frequent usage of ECD 
as well as the introduction of new surgical techniques may affect the incidence of PRS, 
depending on the era, a chronological factor. Also, geographical areas with low organ donor 
conversion rates and acute shortage of organs for transplantation will invariably result in 
higher usage rates of ECD, as well as sicker recipients due to longer waiting times. 
Therefore, the incidence of PRS will vary with geographical area. The interpretation of those 
results also needs to take chronological and geographical factors into account as 
confounding factors. 
4. Risk factors for PRS 
Well-established risk factors and recognized mechanisms associated with PRS include: i) 
volume status of the recipient before reperfusion, ii) myocardial depression due to 
embolization of cold preservation solution into the systemic circulation, and  iii) release of 
vasoactive pro-inflammatory factors originating in activated Kupffer cells of the post-
ischemic liver graft. 
4.1 Pre-reperfusion volume status 
The liver is an important reservoir of blood, containing a total of about 250-500ml or 18-
30ml/100g of blood. In liver transplantation, the donor liver graft will be rapidly filled with 
recipient blood following revascularization of the portal vein, resulting in immediate 
volume shifts and occasionally, hypotension. De La Morena et al. determined that an 
insufficient increase in preload is a main causative factor of PRS (or reperfusion 
hypotension) in an observational study using transesophageal echocardiography (TEE). 
Maintaining a high cardiac output is essential to ensure adequate perfusion of organs in 
liver transplantation. However, high cardiac output can be accomplished by maintaining 
preload, which may be difficult given that the operation itself is associated with major 
changes in volume and afterload, in addition to blood loss, third space losses, and ongoing 
ascites production. This result will support the hypothesis that volume shift is one of the 
main components of reperfusion hypotension and maintaining adequate preload before 
reperfusion is crucial. Also, size mismatch between donor and recipient can cause additional 
volume shifts, as evidenced by the fact that a large-for-size donor relative to recipient body 
size causes more severe reperfusion hypotension. The BSA index (BSAi) may help to more 
accurately match donor and recipient organs in whole organ liver transplantation. 
4.2 Myocardial performance 
In addition to volume shifts, a change in myocardial performance is another component of 
reperfusion hypotension/PRS. Myocardial performance is reduced by a decrease in 
temperature, acid-base and electrolyte disturbances, which are all caused by the flushing of 
residual preservation solution into the systemic circulation after revascularization of the 
graft. Acidosis following reperfusion due to release of acidic fluid from ischemic bowel and 
liver graft is a common finding in liver transplantation. Acute acidosis can cause 
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tachycardia, dysrrythmias, and severe myocardial depression by producing changes in 
resting membrane potential and threshold potential and an increase in the rate of phase IV 
depolarization. Therefore the use of VVB has been proposed to decrease the incidence of 
PRS by minimizing small bowel edema/ischemia with varying results. 
4.3 Donor factors 
Lastly, the release of inflammatory factors from the post-ischemic donor liver graft into the 
recipient systemic circulation also can trigger a systemic inflammatory chain reaction that 
can lead to systemic hypotension and multi-organ dysfunction. Therefore, the quality of the 
donor can be a risk factor for PRS, and postoperative graft function (primary non-function, 
and graft survival). A donor organ with certain characteristics such as extreme age, adverse 
past medical history, preexisting liver damage or disease, obesity, hemodynamic 
instabilities, deceased cardiac donor (DCD), risk of sepsis and malignancies, hypernatremia, 
and prolonged ICU stay, may be more susceptible to ischemia, and more likely to have 
higher incidence of primary non-function (PNF), delayed function or subsequent risk for 
reduction in long-term graft survival. Similarly, several studies have attempted to identify 
donor risk factors for PRS. Hilmi et al reported warm ischemia time as a risk factor and 
more recently Paugam-Burtz, et al reported cold ischemia time is also a risk for PRS. In 
addition to those prior studies, donor age is an important risk factor for PRS. The older 
donor graft has a lower tolerance for hypoxia, and a greater susceptibility to reperfusion 
injury, probably due to metabolic changes associated with senescence, age related 
atherosclerotic changes in vascular structures , or steatotic changes of the parenchyma. The 
type of preservation solution and the graft flushing techniques have also been shown to 
affect the severity of PRS. 
5. Strategy for the intraoperative management of PRS 
Warm recipient blood flows into the cold organ after revascularization of the portal vein, 
causing immediate volume shifts, re-oxygenation of the ischemic organ, and outflow of cold 
preservation solution saturated with vasoactive pro-inflammatory factors. Optimization of 
volume status in the recipient prior to reperfusion may minimize hemodynamic changes 
related to volume shifts by maximizing hemodynamic capacity to maintain good perfusion 
pressure throughout the liver graft, especially the large-for-size graft. TEE coupled with 
close monitoring of hemodynamic parameters with continuous cardiac output (CO)/SvO2, 
and standard cardiac monitors are particularly helpful to ensure hemodynamic integrity of 
the recipient. To obtain sufficient perfusion of the liver graft, especially through the hepatic 
microcirculation, vasodilating agents such as prostaglandin or calcium channel blockers can 
be used but with caution since those agents can aggravate hemodynamic instability. To 
minimize the sudden outflow of preservation solution from the liver graft, flushing the 
organ prior to reperfusion has been used and currently proposed as the most effective way 
of preventing hemodynamic instability associated with the inadvertent release of 
preservation solution. Ingredients of the flush solution as well as rate of infusion, 
temperature of flush solution, and amount of solution are still under investigation. Gradual 
and homogeneous perfusion of the organ by machine perfusion immediately prior to 
implantation may improve graft function by effectively removing the pro-inflammatory 
factors from the graft microcirculation, may reduce PRS and improve short and long term 
graft survival, especially in the ECD.  Preemptive use of vasopressors may help maintain the 
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systemic blood pressure but may not improve the % change in blood pressure or graft 
outcome. Preemptive use of oxidative free radical scavenging agents or attempts at 
counteracting vasoactive inflammatory factors is another area of research. For example, 
methylene blue has been used to scavenge nitric oxide related vasodilation in various shock 
states. Also, several oxidative free radical scavengers, vasodilators (inhaled nitric oxide, 
prostaglandin E), and Ibuprofen (cyclooxygenase inhibitor) have been studied as a way to 
suppress the pro-inflammatory cascade post-reperfusion. The benefits of these treatment 
strategies on PRS and postoperative graft function are inconclusive, and larger clinical trials 
are needed. This will require a consortium of leading academic liver transplant centers to 
conduct multicenter clinical trials. To minimize the impairment of cardiac performance 
following reperfusion, electrolyte abnormalities, especially hypocalcemia and hyperkalemia 
need to be corrected prior to reperfusion. Magnesium replacement may need to be 
considered, especially when there is hypocalcemia due to intraoperative transfusion and 
citrate intoxication. Citrate binds magnesium as well as calcium, causing acute 
hypomagnesemia. 
6. Conclusions 
After having contributed to the establishment of liver transplantation as a safe and 
definitive treatment option for patients with end stage liver disease, including those with 
ESLD complicated by hepatocarcinomas, in the latter half of the 20th century, the next 
challenge to Transplant Anesthesiologists and Critical Care Specialists in the 21st is to 
continue to improve the perioperative management of the donor and organ transplant 
recipient during the most critical period of the liver transplant procedure namely, 
revascularization, reperfusion and re-oxygenation of the graft. This effort will undoubtedly 
require multicenter research collaborations, the determination of better and more reliable 
end-points for PRS and graft function, and the institution and conduct of multicenter clinical 
trials. Inevitably research will most likely reveal the need for a multi-factorial treatment 
strategy to preempt or mitigate PRS and the deterioration of graft function, especially of the 
ECD graft. This effort comprises preconditioning of the donor, preservation and post 
condition of the recipient transplanted, a process that can be succinctly described as ‘organ 
resuscitation’. Better post-transplant outcomes will decrease the costs involved in re-
transplantation, and prolonged ICU and hospital stays.  
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